New NICE guidance: Deuruxolitinib is now recommended for severe alopecia areata.
The twice-daily pill could help over 13,000 people in England living with this autoimmune condition.
Read the final guidance: nice.org.uk/guidance/indev…
Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.


